These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 28989886)
1. Comparative Evaluation of Safety and Efficacy of Glimepiride and Sitagliptin in Combination with Metformin in Patients with Type 2 Diabetes Mellitus: Indian Multicentric Randomized Trial - START Study. Devarajan TV; Venkataraman S; Kandasamy N; Oomman A; Boorugu HK; Karuppiah SKP; Balat D Indian J Endocrinol Metab; 2017; 21(5):745-750. PubMed ID: 28989886 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin. Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P; Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of sitagliptin/metformin fixed-dose combination compared with glimepiride in patients with type 2 diabetes: A multicenter randomized double-blind study. Kim SS; Kim IJ; Lee KJ; Park JH; Kim YI; Lee YS; Chung SC; Lee SJ J Diabetes; 2017 Apr; 9(4):412-422. PubMed ID: 27229178 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and Tolerability of Sitagliptin Compared with Glimepiride in Elderly Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control: A Randomized, Double-Blind, Non-Inferiority Trial. Hartley P; Shentu Y; Betz-Schiff P; Golm GT; Sisk CM; Engel SS; Shankar RR Drugs Aging; 2015 Jun; 32(6):469-76. PubMed ID: 26041585 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of efficacy and tolerability of glimepiride and metformin combination: a multicentric study in patients with type-2 diabetes mellitus, uncontrolled on monotherapy with sulfonylurea or metformin. Pareek A; Chandurkar NB; Salkar HR; Borkar MS; Tiwari D Am J Ther; 2013 Jan; 20(1):41-7. PubMed ID: 21326082 [TBL] [Abstract][Full Text] [Related]
6. HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin. Ahrén B; Johnson SL; Stewart M; Cirkel DT; Yang F; Perry C; Feinglos MN; Diabetes Care; 2014 Aug; 37(8):2141-8. PubMed ID: 24898304 [TBL] [Abstract][Full Text] [Related]
7. Comparing the efficacy and safety profile of sitagliptin versus glimepiride in patients of type 2 diabetes mellitus inadequately controlled with metformin alone. Srivastava S; Saxena GN; Keshwani P; Gupta R J Assoc Physicians India; 2012 Mar; 60():27-30. PubMed ID: 22799111 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial. Arechavaleta R; Seck T; Chen Y; Krobot KJ; O'Neill EA; Duran L; Kaufman KD; Williams-Herman D; Goldstein BJ Diabetes Obes Metab; 2011 Feb; 13(2):160-8. PubMed ID: 21199268 [TBL] [Abstract][Full Text] [Related]
9. Sitagliptin 100 mg vs glimepiride 1-3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM). Kesavadev J; Pillai PBS; Shankar A; Krishnan G; Jothydev S Endocr Connect; 2017 Nov; 6(8):748-757. PubMed ID: 28982699 [TBL] [Abstract][Full Text] [Related]
10. Randomized trial assessing the safety and efficacy of sitagliptin in Chinese patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea alone or combined with metformin. Ba J; Han P; Yuan G; Mo Z; Pan C; Wu F; Xu L; Hanson ME; Engel SS; Shankar RR J Diabetes; 2017 Jul; 9(7):667-676. PubMed ID: 27502307 [TBL] [Abstract][Full Text] [Related]
12. Glimepiride strongly enhances the glucose-lowering effect in triple oral antidiabetes therapy with sitagliptin and metformin for Japanese patients with type 2 diabetes mellitus. Arai K; Maeda H; Sirabe S; Yamamoto R; Yamauchi M; Hirao T; Hirao S; Hirao K Diabetes Technol Ther; 2013 Apr; 15(4):335-41. PubMed ID: 23480592 [TBL] [Abstract][Full Text] [Related]
13. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study. Roberts VL; Stewart J; Issa M; Lake B; Melis R Clin Ther; 2005 Oct; 27(10):1535-47. PubMed ID: 16330290 [TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial. Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018 [TBL] [Abstract][Full Text] [Related]
15. A comparative study of the effects of a dipeptidyl peptidase-IV inhibitor and sulfonylurea on glucose variability in patients with type 2 diabetes with inadequate glycemic control on metformin. Kim HS; Shin JA; Lee SH; Kim ES; Cho JH; Son HY; Yoon KH Diabetes Technol Ther; 2013 Oct; 15(10):810-6. PubMed ID: 24050737 [TBL] [Abstract][Full Text] [Related]
16. Teneligliptin versus sitagliptin in Korean patients with type 2 diabetes inadequately controlled with metformin and glimepiride: A randomized, double-blind, non-inferiority trial. Kim Y; Kang ES; Jang HC; Kim DJ; Oh T; Kim ES; Kim NH; Choi KM; Kim SR; You J; Kim SJ; Lee MK Diabetes Obes Metab; 2019 Mar; 21(3):631-639. PubMed ID: 30362280 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of sitagliptin when added to ongoing therapy in korean subjects with type 2 diabetes mellitus. Chung HS; Lee MK Diabetes Metab J; 2011 Aug; 35(4):411-7. PubMed ID: 21977462 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of sitagliptin as compared with glimepiride in Japanese patients with type 2 diabetes mellitus aged ≥ 60 years (START-J trial). Terauchi Y; Yamada Y; Ishida H; Ohsugi M; Kitaoka M; Satoh J; Yabe D; Shihara N; Seino Y Diabetes Obes Metab; 2017 Aug; 19(8):1188-1192. PubMed ID: 28294488 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents. Li CJ; Liu XJ; Bai L; Yu Q; Zhang QM; Yu P; Yu DM Diabetol Metab Syndr; 2014; 6():69. PubMed ID: 24917890 [TBL] [Abstract][Full Text] [Related]
20. Optimal candidates for the switch from glimepiride to sitagliptin to reduce hypoglycemia in patients with type 2 diabetes mellitus. Kim HM; Lim JS; Lee BW; Kang ES; Lee HC; Cha BS Endocrinol Metab (Seoul); 2015 Mar; 30(1):84-91. PubMed ID: 25325279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]